Adamis Pharmaceuticals to conduct public offering of stock, warrants

Bookrunner CRT Capital Group assists in selling shares and warrants

By Devika Patel

Knoxville, Tenn., Nov. 15 - Adamis Pharmaceuticals Corp. will price a public offering of common stock and five-year warrants with a greenshoe, according to a Form S-1 filed Friday with the Securities and Exchange Commission.

CRT Capital Group LLC is the bookrunner.

Proceeds will be used to make the company's final payment to 3M in its acquisition of the assets connected to the Taper dry powder inhaler technology.

The specialty pharmaceutical company is based in San Diego.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.